Expanding Head and Neck Cancer Treatment Market

The global head and neck cancer treatment market is projected to experience significant growth, driven by factors such as increasing incidence of head and neck cancers, a growing geriatric population, and technological advancements in diagnosis and treatment. The market is segmented by route of administration and therapy, with a growing demand for minimally invasive procedures and oncology-related medical tourism. Leading companies in the market include Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., and Novartis AG.